Key metrics and charts across all fundamental categories.
Stock price and market valuation
CHTR trades at $131.42, a 64.3% decrease year-over-year. Market capitalization stands at $16.49B, down 68.4% from the prior year. Track CHTR price trends and market cap history to understand how the market values this company over time.
Revenue and earnings growth across quarters
$54.64B in TTM revenue declined 0.9% YoY, reaching $13.60B last quarter. TTM EBITDA of $12.88B on operating income of $3.21B shows growth is flowing through. Net income of $4.93B TTM confirms the company is converting revenue into profit. Revenue is contracting — assess whether this is cyclical or structural.
Assets, cash, debt, and leverage
With $154.64B in assets and $94.41B in long-term debt, the D/E of 5.8 indicates elevated leverage — the company has significant financial risk and may struggle in a downturn.
Price multiples and return ratios
At 3.3x P/E, the stock trades below market averages — potentially undervalued. P/S of 0.3x and P/B of 1.0x provide additional context. Assess whether the current multiple is justified by the company's growth and profitability trajectory.
Operating efficiency and return metrics
Op. margin of 23.6% is up 0.0% YoY — cost efficiency is improving. Net margin at 8.6%. ROE of 30.1% shows the company generates solid returns on shareholder equity.
Free cash flow, earnings quality, and capital allocation
FCF of $1.45B on $4.30B in operating cash flow. The FCF / Net Income ratio of 0.3x indicates partial cash conversion — earnings quality needs attention. Cash reserves of $517.00M provide financial flexibility. Shares outstanding declined 11.4% YoY — buybacks are returning capital to shareholders.
